Failure of neuronal homeostasis results in common neuropsychiatric phenotypes, Nature, vol.455, pp.912-918, 2008. ,
Key role for gene dosage and synaptic homeostasis in autism spectrum disorders, Trends Genet, vol.26, pp.363-372, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01967134
Spatio-temporal transcriptome of the human brain, Nature, vol.478, pp.483-489, 2011. ,
Reversal of neurological defects in a mouse model of Rett syndrome, Science, vol.315, pp.1143-1147, 2007. ,
Developmental course of autistic social impairment in males, Dev. Psychopathol, vol.21, pp.127-138, 2009. ,
Six developmental trajectories characterize children with autism, Pediatrics, vol.129, pp.1112-1120, 2012. ,
Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model, Pediatrics, vol.125, pp.17-23, 2010. ,
The ESSENCE in child psychiatry: Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations, Res. Dev. Disabil, vol.31, pp.1543-1551, 2010. ,
Critical period plasticity in local cortical circuits, Nat. Rev. Neurosci, vol.6, pp.877-888, 2005. ,
Brain mechanisms in early language acquisition, Neuron, vol.67, pp.713-727, 2010. ,
Critical period regulation, Annu. Rev. Neurosci, vol.27, pp.549-579, 2004. ,
Fine-tuning of pre-balanced excitation and inhibition during auditory cortical development, Nature, vol.465, pp.927-931, 2010. ,
Autism: a "critical period" disorder?, Neural Plast, p.921680, 2011. ,
Advances in autism genetics: on the threshold of a new neurobiology, Nat. Rev. Genet, vol.9, pp.341-355, 2008. ,
Genetic architecture in autism spectrum disorder, Curr. Opin. Genet. Dev, vol.22, pp.229-237, 2012. ,
Mutations causing syndromic autism define an axis of synaptic pathophysiology, Nature, vol.480, pp.63-68, 2011. ,
Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2, Nature, vol.486, pp.256-260, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01470252
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction, Nature, vol.472, pp.437-442, 2011. ,
A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice, Science, vol.318, pp.71-76, 2007. ,
Activity-dependent neuronal signalling and autism spectrum disorder, Nature, vol.493, pp.327-337, 2013. ,
FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism, Cell, vol.146, pp.247-261, 2011. ,
Allen Brain Atlas: an integrated spatio-temporal portal for exploring the central nervous system, Nucleic Acids Res, vol.41, pp.996-1008, 2012. ,
Proline-rich synapse-associated protein-1/cortactin binding protein 1 (ProSAP1/CortBP1) is a PDZ-domain protein highly enriched in the postsynaptic density, J. Neurosci, vol.19, pp.6506-6518, 1999. ,
Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses, Proc. Natl. Acad. Sci. USA, vol.96, pp.1100-1105, 1999. ,
The role of SAP97 in synaptic glutamate receptor dynamics, Proc. Natl. Acad. Sci. USA, vol.107, pp.3805-3810, 2010. ,
SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism, Mol. Psychiatry, vol.17, pp.71-84, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00644264
Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses, Cell, vol.151, pp.709-723, 2012. ,
Developmental trajectories in children with and without autism spectrum disorders: the first 3 years, Child Dev, vol.84, pp.429-442, 2013. ,
When is the brain enlarged in autism? A metaanalysis of all brain size reports, Biol. Psychiatry, vol.58, pp.1-9, 2005. ,
Differences in white matter fiber tract development present from 6 to 24 months in infants with autism, Am. J. Psychiatry, vol.169, pp.589-600, 2012. ,
Developmental trajectories of resting EEG power: an endophenotype of autism spectrum disorder, PLoS ONE, vol.7, p.39127, 2012. ,
Atypical face versus object processing and hemispheric asymmetries in 10-month-old infants at risk for autism, Biol. Psychiatry, vol.66, pp.950-957, 2009. ,
Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome, Proc. Natl. Acad. Sci. USA, vol.102, pp.11557-11562, 2005. ,
Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice, Proc. Natl. Acad. Sci. USA, vol.106, pp.2029-2034, 2009. ,
Behavioral profiles of mouse models for autism spectrum disorders, Autism Res, vol.4, pp.5-16, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01470286
AMPAKINE enhancement of social interaction in the BTBR mouse model of autism, Neuropharmacology, vol.64, pp.268-282, 2013. ,
Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features, Hum. Mol. Genet, vol.9, pp.1145-1159, 2000. ,
Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human FMR1 transgene, Behav. Neurosci, vol.122, pp.1371-1377, 2008. ,
Social behavior in Fmr1 knockout mice carrying a human FMR1 transgene, Behav. Neurosci, vol.122, pp.710-715, 2008. ,
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes, Nature, vol.459, pp.569-573, 2009. ,
Altered Neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome, Behav. Brain Res, vol.208, pp.96-105, 2010. ,
Correction of fragile X syndrome in mice, Neuron, vol.56, pp.955-962, 2007. ,
Reversal of fragile X phenotypes by manipulation of A?PP/ A? levels in Fmr1KO mice, PLoS ONE, vol.6, p.26549, 2011. ,
Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model, Genes Brain Behav, vol.11, pp.586-600, 2012. ,
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression, Neuron, vol.49, pp.341-348, 2006. ,
Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2deficient mice, Hum. Mol. Genet, vol.22, pp.358-371, 2013. ,
Wild-type microglia arrest pathology in a mouse model of Rett syndrome, Nature, vol.484, pp.105-109, 2012. ,
Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model, J. Med. Genet, vol.46, pp.94-102, 2009. ,
Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of fragile X syndrome, Brain Res, vol.1439, pp.7-14, 2012. ,
Genetic reduction of muscarinic M-4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS), Behav. Brain Res, vol.228, pp.1-8, 2012. ,
Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function, Nature, vol.486, pp.261-265, 2012. ,
Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior, J. Neurosci, vol.30, pp.2115-2129, 2010. ,
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome, Proc. Natl. Acad. Sci. USA, vol.109, pp.14230-14235, 2012. ,
Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits, Cell, vol.147, pp.235-246, 2011. ,
Risperidone in children with autism and serious behavioral problems, N. Engl. J. Med, vol.347, pp.314-321, 2002. ,
The autistic neuron: troubled translation?, Cell, vol.135, pp.401-406, 2008. ,
Rapamycin for treating tuberous sclerosis and autism spectrum disorders, Trends Mol. Med, vol.17, pp.78-87, 2011. ,
Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations, J. Med. Genet, vol.42, pp.318-321, 2005. ,
Deregulation of EIF4E: a novel mechanism for autism, J. Med. Genet, vol.46, pp.759-765, 2009. ,
Phosphatase and tensin homolog (PTEN) gene mutations and autism: literature review and a case report of a patient with Cowden syndrome, autistic disorder, and epilepsy, J. Child Neurol, vol.27, pp.392-397, 2012. ,
Reversal of learning deficits in a Tsc2 +/? mouse model of tuberous sclerosis, Nat. Med, vol.14, pp.843-848, 2008. ,
Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice, Nature, vol.488, pp.647-651, 2012. ,
Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin, Neurobiol. Dis, vol.45, pp.369-380, 2012. ,
Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice, J. Neurosci, vol.29, pp.1773-1783, 2009. ,
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial, Lancet, vol.381, pp.125-132, 2013. ,
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis, N. Engl. J. Med, vol.358, pp.140-151, 2008. ,
Treatment of neurodevelopmental disorders in adulthood, J. Neurosci, vol.32, pp.14074-14079, 2012. ,
Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice, Neuron, vol.74, pp.49-56, 2012. ,
Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056, Sci. Transl. Med, vol.3, pp.64-65, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00655289
Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP, Neuropsychopharmacology, vol.35, pp.976-989, 2010. ,
Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism, Science, vol.338, pp.128-132, 2012. ,
Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome, Neuron, vol.77, pp.243-250, 2013. ,
Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of fragile X syndrome, Brain Res, vol.1439, pp.7-14, 2012. ,
Open-label add-on treatment trial of minocycline in fragile X syndrome, BMC Neurol, vol.10, p.91, 2010. ,
Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures, Am. J. Intellect. Dev. Disabil, vol.115, pp.433-443, 2010. ,
Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations, Nat. Genet, vol.43, pp.585-589, 2011. ,
Autistic-like behaviour in Scn1a +/? mice and rescue by enhanced GABA-mediated neurotransmission, Nature, vol.489, pp.385-390, 2012. ,
Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABA B receptors with arbaclofen, Sci. Transl. Med, vol.4, pp.152-128, 2012. ,
Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial, Sci. Transl. Med, vol.4, pp.152-127, 2012. ,
A randomised controlled trial of bumetanide in the treatment of autism in children, Transl. Psychiatry, vol.2, p.202, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00952877
Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome-Mecp2 gene dosage effects and BDNF expression, Eur. J. Neurosci, vol.27, pp.3342-3350, 2008. ,
Social peers rescue autismrelevant sociability deficits in adolescent mice, Autism Res, vol.4, pp.17-27, 2011. ,
Enriched rearing improves behavioral responses of an animal model for CNV-based autistic-like traits, Hum. Mol. Genet, vol.21, pp.3083-3096, 2012. ,
Early behavioral intervention is associated with normalized brain activity in young children with autism, J. Am. Acad. Child Adolesc. Psychiatry, vol.51, pp.1150-1159, 2012. ,
Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4, Genes Brain Behav, vol.11, pp.928-941, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01470265
Fmr1 KO mice as a possible model of autistic features, Scientific World Journal, vol.6, pp.1164-1176, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00110405
Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function, Hum. Mol. Genet, 2013. ,
A systematic review of medical treatments for children with autism spectrum disorders, Pediatrics, vol.127, pp.1312-1321, 2011. ,
Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders, Trends Pharmacol. Sci, vol.33, pp.669-684, 2012. ,
Rare diseases, orphan drugs and their regulation: questions and misconceptions, Nat. Rev. Drug Discov, vol.9, pp.921-929, 2010. ,
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism, Arch. Gen. Psychiatry, vol.66, pp.583-590, 2009. ,
A nationwide survey on quality of life and associated factors of adults with high-functioning autism spectrum disorders, Autism, vol.17, pp.15-26, 2013. ,
Phenotypic heterogeneity of genomic disorders and rare copynumber variants, N. Engl. J. Med, vol.367, pp.1321-1331, 2012. ,
Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders, PLoS Genet, vol.8, p.1002521, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00834560
The 22q13.3 deletion syndrome (Phelan-McDermid syndrome), Mol. Syndromol, vol.2, pp.186-201, 2012. ,
Phelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype?, Neuropsychiatr. Dis. Treat, vol.8, pp.175-179, 2012. ,
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia, Proc. Natl. Acad. Sci. USA, vol.107, pp.7863-7868, 2010. ,
Simons Variation in Individuals Project (Simons VIP): a genetics-first approach to studying autism spectrum and related neurodevelopmental disorders, Neuron, vol.73, pp.1063-1067, 2012. ,
Rett syndrome diagnostic criteria: lessons from the Natural History Study, Ann. Neurol, vol.68, pp.951-955, 2010. ,
Using whole-exome sequencing to identify inherited causes of autism, Neuron, vol.77, pp.259-273, 2013. ,
Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons, Nature, vol.481, pp.185-189, 2012. ,
HDAC4 governs a transcriptional program essential for synaptic plasticity and memory, Cell, vol.151, pp.821-834, 2012. ,
Neuronal regulation of alternative pre-mRNA splicing, Nat. Rev. Neurosci, vol.8, pp.819-831, 2007. ,
Mechanisms of dendritic mRNA transport and its role in synaptic tagging, EMBO J, vol.30, pp.3540-3552, 2011. ,
Dendritic protein synthesis in the normal and diseased brain, Neuroscience, vol.232, pp.106-127, 2012. ,
Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation, EMBO J, vol.32, pp.954-969, 2013. ,
Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders, Science, vol.338, pp.1619-1622, 2012. ,
Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy, Science, vol.338, pp.394-397, 2012. ,
FMRP targets distinct mRNA sequence elements to regulate protein expression, Nature, vol.492, pp.382-386, 2012. ,
Autism-related deficits via dysregulated eIF4E-dependent translational control, Nature, vol.493, pp.371-377, 2013. ,
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism, Nat. Genet, vol.34, pp.27-29, 2003. ,
URL : https://hal.archives-ouvertes.fr/inserm-00124744
Genetic advances in autism: heterogeneity and convergence on shared pathways, Curr. Opin. Genet. Dev, vol.19, pp.271-278, 2009. ,
Social behavior in Fmr1 knockout mice carrying a human FMR1 transgene, Behav. Neurosci, vol.122, pp.710-715, 2008. ,
Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP, Neuropharmacology, vol.49, pp.1053-1066, 2005. ,
Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2, Proc. Natl. Acad. Sci. USA, vol.104, pp.1931-1936, 2007. ,
Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome, J. Neurosci, vol.27, pp.10912-10917, 2007. ,
Pharmacological treatment of Rett syndrome improve breathing and survival in a mouse model, Med. Sci, vol.23, pp.805-807, 2007. ,
Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model, Respir. Physiol. Neurobiol, vol.160, pp.116-121, 2008. ,